The aim of our research was to evaluate the prevalence of elevated cardiac biomarkers (NT-proBNP, hs-troponin T, hs-troponin I) and their correlation with the risk of hyperuricemia in the general US adults without known cardiovascular disease. The gene discussed is NPPB; the disease is hyperuricemia.